News

A total of 45 studies were selected for the systematic review, with non-White patients being underrepresented across them all.

New findings observing links between visual acuity, disease progression and risk loci could inform new clinical studies of the leading cause of irreversible vision loss.

Future studies should focus on subgroups of patients with Crohn’s disease treated with ustekinumab.

Dr. Greenberg urges the ACIP to update their vaccine guidelines for patients 65 years and older to recommend high-dose flu vaccines.

Monthly IV pegcetacoplan was associated with 39% reduced risk of progression from incomplete to complete RPE and outer retinal atrophy.

February 3 is National Women's Physician Day.

Both single-donor and multiple-donor fecal microbiota transplantation had clinical cure rates over 80%.

The FDA began conducting research to support the development of bioequivalence recommendations for cyclosporine ophthalmic emulsion in 2012.

Investigators added that the meta-analysis contributed to the comparative effectiveness literature for AGA therapies regarding the compared interventions.

Investigators observed significant increases in the rate of encounters with children and adolescents with autism spectrum disorder, as well as those with anxiety and depression.

Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.

The application for NVX-CoV2373 is supported by promising data from 2 multinational trials conducted prior to the spread of the Omicron variant.

New data show use exceeding the recommended daily dose for sleep aid has increased nearly 4-fold in the last 15 years.

Hospitals with lower-than-expected CDI antimicrobial use had on average fewer beds, shorter length of stay, and higher proportion of undergraduate or nonteaching medical school affiliation.

The study suggested children born extremely premature may remain "preterm for life," with ophthalmic sequelae persisting into adulthood.

New data from the NAVIGATOR study found that tezepelumab was associated with fewer asthma exacerbations throughout all seasons of the year compared to placebo.

Dr. Shrine and colleagues conducted the largest genome-wide association study of coexisting asthma and COPD to date in a 2-stage design incorporating a total of 13 studies.

The recombinant von Willebrand factor, VONVENDI, receives approval from the FDA to treat patients living with severe type 3 von Willebrand disease.

Resmetirom is being studied as a potential treatment for both NAFLD and NASH.

The approval of the Spikevax vaccine was based on safety and efficacy data approximately 6 months after the second dose.

Rates of aspirin use for preeclampsia prophylaxis were observed in a minority of women with risk factors including pre-pregnancy diabetes, obesity, or chronic hypertension.

A new assessment of payer incentives offered through physician organizations suggest the dominating emphasis of quantity over quality in pay.

Pfizer’s statement does not include a reason for the Complete Response Letter the FDA issued regarding the Biologics License Application for somatrogon for Pediatric Growth Hormone Deficiency.

The majority of drugs in development for IBD target inflammation.

Dr. Bagel details newer topical therapies such as tapinarof and roflumilast, and speaks to how greater access to these therapies is needed among psoriasis patients.

Though continuous positive airway pressure and high-flow nasal oxygen have both been recommended for acute hypoxemic respiratory failure in patients infected with the COVID-19 virus, the effectiveness and safety of these strategies were uncertain.

Don't Miss a Beat is Practical Cardiology's expert-led podcast. The monthly podcast, which is hosted by Drs. Greene and Vaduganathan, will provide a regular news roundup of the latest evidence and clinical trial insights across cardiovascular, renal, and metabolic diseases.